Studies on the Redox Characteristics of Ferrioxamine E

Thermodynamic parameters for the reduction of ferrioxamine E as calculated from redox potentials determined at four different temperatures were found to be ΔH≠=7.1±3.4 kJ mol−1 and ΔS≠=−146 J mol−1 K−1. The negative entropy value is large, because the decrease in the charge at the metal center and an increase in its ionic radius force the structure of the complex to become less rigid and resemble the desferrisiderophore. The hydrophilic groups of the system are now (relatively more) available for solvent interaction. Thus, a large negative entropy change accompanies the reduction of the complex. Kinetics of reduction of ferrioxamine by VII, CrII, EuII, and dithionite were measured at different temperatures and by dithionite at different pH values. The CrII and EuII reactions proceed by an inner‐sphere mechanism and have second‐order rate constants at 25° of 1.37×104 and 1.23×105 M−1 s−1, respectively. For the VII reduction, the corresponding rate constant was 1.89×103 M−1 s−1. The activation parameters for the VII reduction were ΔH≠ = 8.3 kJ mol−1; ΔS≠ =−154 J mol−1 K−1. These values are indicative of an outer‐sphere mechanism for VII reduction. The reduction by dithionite is half order in dithionite concentration indicating that SO$\rm{{_{2}^{-}}}$. is the sole reducing species. log of reduction rate constants of different trihydroxamates by this reductant were correlated with their respective redox potentials, and the variation was found to be in approximate correspondence with the expectations of Marcus relationship.

[1]  A. L. Crumbliss,et al.  Ternary Complex Formation Facilitates a Redox Mechanism for Iron Release from a Siderophore , 2006, Biometals.

[2]  A. L. Crumbliss,et al.  Coordination Chemistry and Redox Processes in Siderophore-Mediated Iron Transport , 2005 .

[3]  U. Möllmann,et al.  Screening System for Xenosiderophores as Potential Drug Delivery Agents in Mycobacteria , 2001, Antimicrobial Agents and Chemotherapy.

[4]  Jide Xu,et al.  Microbial iron transport via a siderophore shuttle: a membrane ion transport paradigm. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Miller,et al.  Studies and syntheses of siderophores, microbial iron chelators, and analogs as potential drug delivery agents. , 2000, Current medicinal chemistry.

[6]  T. J. Brickman,et al.  Electrochemical Behavior of the Fe(III) Complexes of the Cyclic Hydroxamate Siderophores Alcaligin and Desferrioxamine E. , 1999, Inorganic chemistry.

[7]  J. Neilands,et al.  Siderophores: Structure and Function of Microbial Iron Transport Compounds (*) , 1995, The Journal of Biological Chemistry.

[8]  J. Heesemann,et al.  Virulence of Yersinia enterocolitica is closely associated with siderophore production, expression of an iron‐repressible outer membrane polypeptide of 65 000 Da and pesticin sensitivity , 1993, Molecular microbiology.

[9]  J. Mcardle,et al.  Kinetics of reduction of ferrichrome and ferrichrome A by chromium(II), europium(II), vanadium(II), and dithionite , 1984 .

[10]  M. Abdallah,et al.  The Siderochromes of Non-fluorescent Pseudomonads: Production of Nocardamine by Pseudomonas stutzeri , 1980 .

[11]  K. Raymond,et al.  Siderophore electrochemistry: relation to intracellular iron release mechanism. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Lambeth,et al.  The kinetics and mechanism of reduction of electron transfer proteins and other compounds of biological interest by dithionite. , 1973, The Journal of biological chemistry.

[13]  I. G. Young,et al.  Enterochelin System of Iron Transport in Escherichia coli: Mutations Affecting Ferric-Enterochelin Esterase , 1972, Journal of bacteriology.

[14]  T. Emery Role of ferrichrome as a ferric ionophore in Ustilago sphaerogena. , 1971, Biochemistry.

[15]  J. Espenson,et al.  Kinetic study of the electron-transfer reaction between europium(II) and iron(III) in solutions containing perchlorate and chloride ions , 1968 .

[16]  C. Ratledge Iron, mycobacteria and tuberculosis. , 2004, Tuberculosis.

[17]  E. Wawrousek,et al.  Spectroelectrochemistry of ferrioxamine B, ferrichrome, and ferrichrome A , 1982 .

[18]  S. Kazmi Kinetics of reduction of ferrioxamine B by chromium(II), vanadium(II), and dithionite , 1982 .